Bottom line
What is DLHIX's expense ratio?
DLHIX's expense ratio is 0.96%, or about $96 a year on every $10,000 invested. That is more expensive than 51% of health care sector funds we track (median 0.96%). It has no front-end sales load.
Updated Jul 29, 2026
DLHIX fee table
| Net expense ratio | 0.96% |
|---|---|
| Gross expense ratio | 1.01% |
| Management fee | 0.84% |
| 12b-1 (distribution) fee | 0% |
| Other expenses | 0.17% |
| Fee waiver / reimbursement | -0.05% |
| Max front-end sales load | 0% |
| Max deferred sales charge | 0% |
Source: Fund prospectus fee table, filed Jul 29, 2026
What DLHIX costs in dollars
The SEC requires every fund to show what a $10,000 investment would cost, assuming 5% annual returns and that you sell at the end of each period:
| 1 year | 3 years | 5 years | 10 years | |
|---|---|---|---|---|
| DLHIX | $98 | $317 | $553 | $1,232 |
Source: Fund prospectus expense example
The long-run cost of fees
On $100,000 growing at 6% a year for 20 years, a 0.96% expense ratio costs roughly $53,400 in lost growth, versus about $53,400 for the median health care sector fund (0.96%).